Knowledge Distillery

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). About 45% of COVID-19 patients experience…

The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more than four weeks after primary infection, termed "long COVID" or…

Several large-scale electronic health records studies have reported increased diagnostic rates for neuropsychiatric disorders following COVID-19…

Post COVID-19 conditions are complaints and symptoms in patients with a history of probable or confirmed COVID-19 after 3 months of the onset of…

Severe acute respiratory disease coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic.

Sphingosine-one phosphate receptor (S1PR) modulation inhibits S1PR1-mediated lymphocyte migration, lesion formation and positively-impacts on active…

In humans, several respiratory viruses can have neurologic implications affecting both central and peripheral nervous system.

This literature review covers various immunopathologic dysfunctions following COVID-19 infection and their potential implications in development of…

As of May 2022, there have been more than 527 million infections with severe acute respiratory disease coronavirus type 2 (SARS-CoV-2) and over 6.2…

Coronavirus disease 2019 (COVID-19) has caused a historic pandemic of respiratory disease. COVID-19 also causes acute and post-acute neurological…

Despite their proven efficacy and huge contribution to the health of humankind, vaccines continue to be a source of concern for some individuals…

Headache is a frequent symptom of COVID-19, and understanding its management is important for health-care professionals involved in treating the…